Lessons learned from Skylab are applied to methods of dealing with space sickness among crewmembers in their first orbital flight. Early experiences on Skylab 3 led to regularly scheduled scopalamine/dexedrine tablets ingestion. Subsequent experiences on the next Skylab mission established a 75% incidence of the sickness among first-time-in-orbit crewmembers, notably in periods of inactivity rather than work periods. Intramuscular injections are recommended to treat acute space sickness. Preflight transdermal scopalamine plus three or four doses of 5 mg amphetamine are chosen preventive measures, giving 12 hours of efficacy.


    Zugriff

    Zugriff über TIB

    Verfügbarkeit in meiner Bibliothek prüfen


    Exportieren, teilen und zitieren



    Titel :

    Coping with space motion sickness in Spacelab missions


    Beteiligte:
    Graybiel, A. (Autor:in)

    Erscheinungsdatum :

    01.10.1981


    Medientyp :

    Sonstige


    Format :

    Keine Angabe


    Sprache :

    Englisch


    Schlagwörter :




    Space Motion Sickness and Vestibular Experiments in Spacelab

    Oman, Charles M. | SAE Technical Papers | 1982



    Early Spacelab missions

    Pace, R. E., Jr. / Craft, H. G., Jr. | NTRS | 1977